Thursday, August 16, 2018
Company News: Page (1) of 1 - 10/20/17 Email this story to a friend. email article Print this page (Article printing at page facebook
(October 20, 2017)

German-based ALP NUTRITION's ALP SPORT® liquid dietary supplement for athletes was recently featured on CNS Media's, highlighting the product's release into the U.S. market. is Europe's go-to source for news about nutrition and diet trends, providing a huge range of detailed nutrition health, scientific nutrition and nutrition research articles.

“This being one of our first big feature stories of this kind is an exciting milestone for us," ALP NUTRITION's Dr. Oliver Schnorr said. “We're a young, growing company so anything that can help expand our brand awareness both here in Europe and in the U.S. is fantastic for us. We have great products and we're happy to be able to spread the word to's large, built-in audience."

ALP SPORT® is a concentrated liquid nutritional supplement that was originally developed for elite-level athletes, but now it's available to everyone. It contains vitamins C and E, vitamin B-complex, zinc, magnesium, coenzyme Q10, selenium and ALP PHYTO, a specially manufactured plant extract made from of seven different herbs grown organically in the Swiss Alps.

As a liquid supplement, ALP SPORT® can be better absorbed by the body, and the supplement is used by several recognizable German athletes like world champion and former world record hammer thrower Betty Heidler, Deniz Ilbay, a four-time youth boxing world champion, and Benjamin Haugk, a four-time German powerlifting champion and two-time top-10 finisher in the world championships.

To read the article in its entirety, go to

For more information on ALP SPORT® and other ALP NUTRITION® products, visit ALP SPORT® is now available in the United States on at, and with health and wellness e-commerce sites like,, and

Read the full story at

Page: 1

Related Keywords:
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter

  • Neurovascular Devices Market High Revenue at USD 24,650 mn by 2023 | Therapeutic Application Hemorrhagic & Ischemic Strokes | Worldwide Segmentation by MRFR
  • Wearable Medical Devices Global Market Opportunities And Strategies To 2022
  • New Report Identifies Unique Challenges for LGBT Community Facing Alzheimer's and Other Dementias
  • The Buck Institute, Insilico Medicine, and Juvenescence Found Napa Therapeutics to Develop Drugs to Impede Age-Related Disease,
  • The Buck Institute, Insilico Medicine, and Juvenescence Found Napa Therapeutics to Develop Drugs to Impede Age-Related Disease

  • Biotest AG: Cytotect(R) CP prevents transmission of Cytomegalovirus (CMV) to the unborn baby in pregnant women who are infected with CMV for the first time
  • Agenus Receives Second Milestone Payment from Merck
  • Colorado Pain Care Broadens Practice to Include Cancer Patient Treatment in Denver, CO and Surrounding Area
  • Citius Pharmaceuticals Successfully Raises $10 Million
  • ViewRay Announces Pricing of Public Offering of Common Stock

    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines